MIGUEL A RODRIGUEZ-BIGAS to Sulfonamides
This is a "connection" page, showing publications MIGUEL A RODRIGUEZ-BIGAS has written about Sulfonamides.
Connection Strength
0.076
-
A randomised, double blind, placebo controlled study of celecoxib, a selective cyclooxygenase 2 inhibitor, on duodenal polyposis in familial adenomatous polyposis. Gut. 2002 Jun; 50(6):857-60.
Score: 0.028
-
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis. N Engl J Med. 2000 Jun 29; 342(26):1946-52.
Score: 0.024
-
Global quantitative assessment of the colorectal polyp burden in familial adenomatous polyposis by using a web-based tool. Gastrointest Endosc. 2013 Mar; 77(3):455-63.
Score: 0.015
-
Retrospective study of capecitabine and celecoxib in metastatic colorectal cancer: potential benefits and COX-2 as the common mediator in pain, toxicities and survival? Am J Clin Oncol. 2006 Jun; 29(3):232-9.
Score: 0.009